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response to cellular antigens by peripheral
lymphocytes from normal and lung cancer
patients in serum free medium in vitro
(Aaskov and Anthony, Biomedicine, 1973,
19, 369). In common with results published
for the one-stage MMI test, occasional
stimulation of migration has been noted
in this assay. Because of the problem of
assaying migration inhibition factor (MIF)
in the presence of stimulatory material,
attempts have been made to identify the
materials responsible for this stimulation.
Sephadex chromatography yielded an
MIF (mol. wt 20-30,000) and a chemotactic
factor (protein, mol. wt approximately
12,500) from supernates of antigenically
stimulated lymphocytes. The chemotactic
material had no stimulatory effect on
macrophage migration. Stimulation of mi-
gration was observed in fractions from
2 peaks (mol. wt >150,000 and mol. wt
60-70,000). Assay after isoelectric focusing
has shown this to be due to Hb and IgG.
The stimulatory effect of these substances
at certain concentrations has been confirmed.
SPLEEN SIZE IN PATIENTS WITH
BREAST CANCER. J. G. ROBERTS, M.
WISBEY, K. G. LEACH and M. BAUM, Depart-
ments of Surgery and Medical Physics,
Welsh National School of Medicine and the
University Hospital of Wales.
Gamma camera images of the spleen
obtained following the intravenous injection
of heat damaged, autologous, 99Tcm labelled
red cells provide a means of estimating
spleen size in patients.
A new method of calculating spleen size
has been validated in 10 patients. The
computed weight correlated well with the
exsanguinated weight of the excised spleens
(r = 0 9894) wNith 9500 confidence limits
of less than 50 g. This technique has been
applied to 40 patients with breast cancer
and 5 controls. The cancer patients had
significantly larger spleens (P < 0.05) and
spleen size varied with clinicopathological
stage. In 10 patients spleen size has been
estimated at primary treatment and some
6 months later. All patients except one
showed a reduction in spleen size (P < 0 01).
These results suggest that in man, as in
experimental animals, splenomegaly occurs
as a component of the host response to
cancer.
IMMUNITY IN PATIENTS WITH
BREAST CANCER. A. J. COCHRAN, R. M.
MACKIE, C. E. Ross, R. M. GRANT and
D. E. HOYLE, University Department of
Pathology, Western Infirmary, Glasgow.
We have examined tumour directed
immunity and nonspecific immunological
activities in 200 patients with breast car-
cinoma. Techniques employed included skin
testing with recall antigens, the leucocyte
migration technique (LMT), mitogen induced
transformation, an immune adherence tech-
nique, immunoglobulin and complement
assays and T and B cell quantification.
The main findings are: (1) A majority
of breast cancer patients (54%0) showed
evidence of sensitization to tumour derived
materials; (2) sensitization is rare in control
donors (15%). This is true of normal
donors, patients with simple breast disease
and those with other malignancies; (3) in-
hibition of migration was similarly frequent
with homologous (53o%) and autologous
(56%) combinations of antigens and leuco-
cytes; (4) sensitization is less commonly
demonstrable in patients with advanced
disease (27%0); (5) patients with local recur-
rences were as frequently reactive as those
with primary tumours only (60%); (6)
extracts of mastopathic breasts only rarely
inhibited the migration ofleucocytes whether
from cancer patients (210%) or controls
(170%); (7) there is some evidence that
non-cancerous tissues in cancerous breasts
may possess tumour-like antigens. The sig-
nificance of these results, obtained mainly
with the LMT, can be assessed by relating
them to results obtained by the other
techniques.
THE RELATIONSHIP BETWEEN
PROGNOSIS AND LYMPHOCYTE
RESPONSE TO PHA IN BREAST
CANCER. P. M. BOLTON, R. H. WHITE-
HEAD, R. G. NEWCOMBE, S. L. JAMES and
L. E. HUGHES, Departments of Surgery and
Medical Statistics, Welslh National School of
Medicine, Cardiff.
Studies of lymphocyte response to PHA
in cancer patients have shown variable
results, probably due to methodological
differences. We have used a microtest
method with 3 PHA dose levels (0*3 ,ug/ml,
0*8 ,ug/ml and 40) ,ug/ml) to study the
lymphocyte response in 119) patients witl
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fied into 6 groups dependent on pathology,
tumour stage and prognosis, without know-
edge of results of PHA testing.
Control and early cancer patients respond-
ed best to 0-8 Hug PHA/ml but also had a
good response to 0 3 ,ug/ml. Patients with
advanced disease responded maximally to
4
-O ,tg/ml and poorly to 0*3 ,ug/ml. The
highest dose (4 0 ,ug/ml) did not discriminate
as well between the groups, as did the other
2 doses.
A dose-response curve of PHA response
provides more meaningful information than
estimations performed at one dose. Results
correlate with the expected prognosis in
breast cancer.
DETECTION OF DISEASE OF THE
BREAST IN WOMEN ATTENDING
A FAMILY PLANNING ASSOCIATION
CLINIC. T. HAMILTON, R. J. PRESCOTT
and N. B. LOUDON, Department of Clinical
Surgery, and Medical Computing Group,
University of Edinburgh and Family Plan-
ning Association.
A long-term project has been established
to determine the influence of contraceptive
habit on the breast. A total of 13,451
women attending a Family Planning Asso-
ciation Clinic in Edinburgh over a period
of 5 years were offered annual clinical
examination of the breast. In this time
233 women (1 in 58) attending were referred
for surgical opinion; 115 were examined
and reassured; 118 (1 in 114) were submitted
to biopsy; benign lesions were present in
106 and carcinoma detected in 12 women.
Those with carcinoma were all included in
the 17% of the screened population aged
over 35 years (1 in 195). It is concluded
that screening, certainly for carcinoma,
might reasonably be restricted to women
over 35 years, and that below this age,
examination of the breast is probably
unnecessary for those attending for contra-
ceptive advice.
HUMAN TUMOUR CELLS IN SHORT
TERM MONOLAYER CULTURE-
CELL CYCLE KINETICS AND EFFECT
OF HORMONAL STIMULATION. M. E.
LLOYD and P. P. DENDY, Neurology Re-
search Laboratory, The London Hospital.
Cell cycle parameters of lhumain tumouins
in primarv monolayer cultuire -were estab-
lished using a method of continuous exposure
to 3H-TdR. The effect of prednisolone on
kinetics was also studied.
A remarkable similarity in durations of
cell cycle parameters wvvas found between
specimens, S phases averaging 6 h and Tcs
35 h. However, the wide range in values
of maximum Labelling Index (24 -- 950)
indicated considerable differences in the
percentage of cells cycling for different
specimens. For some specimens prednisolone
increased the %0 cycling cells with no effect
on phase durations of cells already cycling.
The durations of S phase are low, compared
with those found by other workers. This
may be due to the short period of growth
in culture but the implications of these
results in the study of S phase of tumour
cells in vivo is uncertain.
Prednisolone studies indicate that some
of the cells unlabelled during long exposure
to 3H-TdR have not necessarily left the
cell cycle permanently.
A PILOT STUDY OF THE VARIA-
BILITY OF NUCLEAR FORM AND
DNA CONTENT IN SMEARS OF
HUMAN URO-EPITHELIAL BLADDER
TUMOURS. R. C. L. FENELEY and
J. M. N. Boss, Bristol United Hospitals
and Department of Physiology, University
of Bristol.
From 19 patients, subsequently observed
for 2-21 years, 27 smears (20 Feulgen and
7 haematoxylin stained) of transurethrally
resected material w"ere made, with inde-
pendent histological grading as " low ",
C average ", or " high ". " Pleiomorphic
smears had nuclei > 20 ,um x > 10 ,um
with indentations > 2 ,tm deep. " Vari-
able" smears had standard deviation
> 0-60 x mean for microdensitometry of
25 nuclei each. The 3 sites without tumours
and 7 patients treated and clear on repeated
review, yielded neither " pleiomorphic " nor
" variable" smears. Of the 4 " pleiomor-
phic" smears 3 were from patients since
dead, and the 4 " variable " from patients
10oW dead (3) or still with recurrence (1).
II the clinically heterogenous " average"
grade are 6 living (none " pleiomorphic ";
1, w%Nith recurrence, " variable ") and 4 dead
(3 " pleiomorphic", none variable, but 3
w8ith no Feulgen stain). (The n-ork was
assis;ted by an M.R.C. grant to J. M. N. Boss.)
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